LATISSE 0.03% EYELASH SOLUTION
FDA nonproprietary name: bimatoprost
For 1 mL
Pharmacies pay
$31.49 – $40.98 filed
1 × $31.49063 to $40.97569 per ML (the 2 NDCs differ)
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$41.21 – $52.13 estimated
NADAC for the pack + 15% + $5.00 fee per fill
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LATISSE 0.03% EYELASH SOLUTION is how the CMS NADAC file names this product. The FDA NDC Directory lists it as bimatoprost, under the trade name “LATISSE”.
FDA gives its dosage form as solution/ drops and its route as ophthalmic.
The labeler, the company named on the label, is Allergan, Inc.
FDA’s Established Pharmacologic Class for it is Prostaglandin Analog.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $31.49 – $40.98 for 1 mL, depending on the NDC ($31.49063 to $40.97569 per ML), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $20.64928 to $26.27422 per ML filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · NADAC explanation codes
All 2 NDCs
- 00023-3616-05 · Allergan, Inc. · $31.49063 per ML · eff. 2026-09-23 filed
- 00023-3616-70 · Allergan, Inc. · $40.97569 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
4 other products in the NADAC file share the FDA nonproprietary name bimatoprost with LATISSE 0.03% EYELASH SOLUTION.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| BIMATOPROST 0.01% EYE DROPS | $42.51553 to $43.41341 per ML filed | $19.73712 per ML filed |
| BIMATOPROST 0.03% EYE DROPS | $4.20713 to $8.85194 per ML filed | $19.73712 per ML filed |
| BIMATOPROST 0.03% EYELASH SOLN | $20.64928 to $26.27422 per ML filed | $19.73712 per ML filed |
| LATISSE 0.03% EYELASH SOLUTION this page | $31.49063 to $40.97569 per ML filed | We don’t know yet |
| LUMIGAN 0.01% EYE DROPS | $102.99002 to $103.10858 per ML filed | $96.71764 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $31.49063 per ML filed.
Of the 6 other products in FDA’s Prostaglandin Analog class priced per ML, 3 have a higher middle NADAC price and 3 a lower one. The one in the middle is BIMATOPROST 0.03% EYELASH SOLN, at $20.64928 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
- Which NDC (the 11-digit number on the package) is this? Pharmacies pay $31.49063 to $40.97569 per ML for this product, depending on the NDC.
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: BIMATOPROST 0.03% EYE DROPS. Ask your pharmacist or prescriber; do not switch on your own.
- How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 mL?
- The FDA package descriptions of this product’s NDCs give different amounts (3 mL, 5 mL). So the card starts at 1 ML; change it to match your prescription.